NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









AiCure

AiCure

Private
New York City, New YorkHealthcare & Life Scienceshttps://aicure.com/

Last Round

VC Round

Jan 23, 2024

Total Funding Raised

$58.75M

Company Overview

AiCure is a health technology company that provides an AI and advanced data analytics platform to monitor patient behavior and improve clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical AI, Patient Engagement, Computer Vision, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

digital biomarkersmedication adherenceclinical trial AIremote patient monitoringpatient engagement platformdecentralized clinical trialsDCTvirtual clinical trialseCOAhealthcare computer visionbehavioral data analysishybrid clinical trialsclinical trial technologyePROcontract research organizationCRO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AiCure Comparables

Compare AiCure with similar companies based on industry and business-model similarity.

AiCure comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Datacubed Health
87%
Koneksa Health
81%
ObvioHealth
81%

AiCure Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 23, 2024
Series CNov 7, 2019
Series BNov 17, 2017
Series AJan 11, 2016

Key People

Founding team and executive leadership

Edward Ikeguchi

Chief Executive Officer

Executive Team

AiCure Investors

Notable investors and investment history

AiCure investors
InvestorRounds
New Leaf Venture PartnersSeries C, Series B, Series A
Palisades GrowthSeries C
NIH RADxGrant
Pritzker Group Venture CapitalSeries C, Series A, Series B
Biomatics Capital PartnersSeries C, Series A, Series B
Baird CapitalSeries C, Series B
SpringRock VenturesSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 199, 510% of current headcount.

  • Jul 10, 2025

    Monthly visitors increased 576% MoM, reaching 14.2K.

AiCure Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AiCure Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AiCure's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range39
Year Founded2010
Last FundingJan 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.